A smaller dose may likely only offer smaller benefits, Zimmermann adds
For example, in the SURMOUNT-4 trial, tirzepatide discontinuers were randomized to a placebo, and they were unaware whether they were receiving tirzepatide or not. In real-world settings, the most common reasons for discontinuation are cost or insurance-related issues, and side effects, with the former predominating, he added
It is intended strictly for in vitro research only and should never be represented as an approved pharmaceutical product or used for clinical applications, patient treatment, or human consumption
This check provides the most accurate coverage information for your specific plan, including estimated copay amounts, prior authorization requirements, and any quantity limits or step therapy mandates